HURA Stock Analysis: Buy, Sell, or Hold?
HURA - TuHURA Biosciences, Inc. Common Stock
$2.14
-0.03 (-1.38%)
▼
5d:
-3.17%
30d:
-12.3%
90d:
-8.15%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 13, 2026
8d
Get Alerted When HURA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: HURA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: HURA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: HURA is currently trading at $2.14, which is considered oversold relative to its 30-day fair value range of $2.15 to $2.36.
Technical Outlook: Technically, HURA is showing sideways momentum. Immediate support is located at $2.00, while resistance sits at $2.30.
Market Sentiment: HURA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.04 (+275.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, HURA is showing sideways momentum. Immediate support is located at $2.00, while resistance sits at $2.30.
Market Sentiment: HURA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.04 (+275.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.15 -
$2.36
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 275.7% below Wall St target ($8.04)
Trading Range Analysis
30-Day Trading Range
$2.15 -
$2.36
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.00
Resistance Level
$2.30
Current Trend
Sideways
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.92
Wall Street Target
$8.04
(+275.7%)
Share & Embed Analysis
Last updated: August 04, 2026 3:07 AM ET
Data refreshes hourly during market hours. Next update: 4:07 AM
Data refreshes hourly during market hours. Next update: 4:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HURA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 50 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 49 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1080 | 57 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$52 | 54 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$127 | 59 HOLD |
